Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
12.17
-1.08 (-8.15%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Adlai Nortye Market Cap
Adlai Nortye has a market cap or net worth of $486.80 million as of April 28, 2026. Its market cap has increased by 606.04% in one year.
Market Cap
486.80M
Enterprise Value
504.22M
1-Year Change
606.04%
Ranking
Category
Stock Price
$12.17
Market Cap Chart
Since the IPO on September 29, 2023, Adlai Nortye's market cap has decreased from $553.50M to $486.80M, a decrease of -12.05%. That is a compound annual growth rate of -4.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 486.80M | 829.04% |
| Dec 31, 2025 | 52.40M | -47.12% |
| Dec 31, 2024 | 99.08M | -70.13% |
| Dec 29, 2023 | 331.73M | -40.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 505.13M |
| Zura Bio | 502.87M |
| Lyell Immunopharma | 500.98M |
| Fulcrum Therapeutics | 495.75M |
| Valneva SE | 491.15M |
| XOMA Royalty | 486.88M |
| 4D Molecular Therapeutics | 482.95M |
| Verastem | 479.62M |